Wang, Hezhi
Wang, Xiaoxiao
Ye, Xueshuai
Ju, Yi
Cao, Nana
Wang, Shuqi
Cai, Jianhui
Article History
Received: 4 May 2022
Accepted: 6 July 2022
First Online: 25 July 2022
Declarations
:
: For the xenograft mice assay, all animal experiments were conducted in the Clinical Research Center of Hebei General Hospital (HBGH). All animal procedures were approved by the Animal Care and Management Committee of HBGH (license number: SCXK2016-0006) and complied with the International Regulations for the Administration of Laboratory Animals. All methods were carried out in accordance with ARRIVE guidelines and regulations (ExternalRef removed). All methods were reported in accordance with ARRIVE guidelines for the reporting of animal experiments. The NOD/SCID mice were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd and the animal use authority was permitted by the Animal Care and Management Committee of HBGH.For the T cell isolation assay, peripheral blood mononuclear cells (PBMCs) derived from healthy donors were obtained from the Hebei Blood Center. All procedures were conducted in accordance with the World Medical Association Declaration of Helsinki and approved by the Medical Research Ethics Committee of Hebei Medical University. All donors gave informed consent to use their samples for research purposes. The informed consent was obtained from all subjects and their legal guardians.
: Not applicable.
: The authors report no conflicts of interest in this work.